Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 21Head and Neck Neoplasms 17Prostatic Neoplasms 15Neoplasms 13Lung Neoplasms 12Radiation Injuries 9Esophageal Neoplasms 8Rectal Neoplasms 7Glioma 7Brain Neoplasms 7Glioblastoma 6Carcinoma, Non-Small-Cell Lung 6Uterine Cervical Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Neoplasm Metastasis 5Carcinoma, Hepatocellular 4Stomach Neoplasms 3Colorectal Neoplasms 3Central Nervous System Neoplasms 3Astrocytoma 3Xerostomia 2Urinary Bladder Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma 2Salivary Gland Neoplasms 2Pelvic Neoplasms 2Osteoradionecrosis 2Lymphedema 2Kidney Neoplasms 2Esthesioneuroblastoma, Olfactory 2

Interventions

Letrozole 2Anastrozole 2trastuzumab deruxtecan 1dalpiciclib 1Vinorelbine 1Standard of Care 1Safety 1Radiotherapy 1In Situ Hybridization, Fluorescence 1Gonadotropin-Releasing Hormone 1Aromatase Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Advanced Breast Cancer × Radiotherapy × Clear all
NCT06776861 2025-01-15

A Prospective, Multicenter, Observational Cohort Study Assessing the Efficacy and Safety of Radiotherapy-sensitized Immunotherapy in Advanced Breast Cancer

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Recruiting
150 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡